Release date: 2017-01-18
On January 9, according to the FDA official website, it first approved Cardio DL, a software for cardiac magnetic resonance imaging AI analysis from Arterys, which can be used to treat a variety of cardiovascular diseases, including congenital heart disease and aorta. Or heart valve disease, etc. It is understood that this software will be used for medical image analysis and provide automatic ventricular segmentation analysis for traditional cardiac MRI scan image data. This step is as accurate as the traditional radiologist needs to manually complete.
In a statement, Arterys said Cardio DL, a cardiac MRI medical imaging analysis system, automatically collects data from the inner and outer contours of the ventricle and provides accurate calculation of ventricular function, which is time-consuming, high-precision, and an image. Analysis can be completed in 10 seconds, much faster than the clinician. Therefore, it is called the artificial intelligence medical image analysis system based on deep learning. It has carried out data verification of thousands of heart cases. The experiment confirmed that the results of the algorithm and the results of the analysis of experienced clinicians are Parallel.
Cardio DL produces contour lines depicting the inner and outer walls of the ventricle
It is reported that this artificial intelligence cardiac MRI medical image analysis system has not only been approved by the FDA 510 (k), the system was also CE certified and approved in Europe in December, which indicates that the software will be allowed for clinical use. As more and more doctors use the Cardio DL software, the cloud platform provided by Arterys will enable the software to collect and analyze the large amount of cardiovascular data obtained by the MR scanner in real time, speeding up the diagnosis of the patient's condition.
Arterys CEO Fabien Beckers said in a statement: "Arterys is committed to developing cloud image analysis software that integrates cloud computing and artificial intelligence technologies, and has dramatically accelerated data-driven medicine through advanced cloud computing medical imaging analysis applications. Transformation, while protecting patient data privacy. Today, the approval of the Cardio DL software is a major regulatory milestone. This application demonstrates the ability to help doctors interpret medical images based on deep learning combined with cloud supercomputing technology. Both precise and automated, eliminating the cumbersome manual tasks that doctors perform on workstations."
Last November, Arterys' 4D blood flow analysis software was also approved by the FDA to speed up cardiac exams by providing clinicians with visual and quantitative data on the anatomy and blood flow inside and around the heart. The software analyzes the blood flow of the heart and the aorta and main veins, a process that can help doctors make decisions about the treatment options for heart patients.
Arteries is currently working with GE to launch the Cardio DL Deep Learning Image Analysis System, which integrates this software into the ViosWorks software system from GE's MRI scanners.
It is reported that Arteries completed a $12 million Series A financing in March 2016. The round of financing was led by Emergent Medical Partners, and investment institutions including GE Ventures and Stanford-StartX Fund were involved.
Next, Arterys plans to extend its reach into another imaging hotspot, tumor imaging, using AI-assisted techniques to track changes in the tumor.
Source: Medical Valley
Sports Food Palatinose,High Quality Palatinose,Natural Palatinose Powder
Shandong Bailong Chuangyuan Bio-tech Co.,Ltd. Qingdao Branch , https://www.qdblcycn.com